A Functional Variant in the {alpha}2B Adrenoceptor Gene, a Positional Candidate on Chromosome 2, Associates With Hypertension.
Author
Summary, in English
In a genome-wide scan in Scandinavians, we found suggestive linkage between early-onset primary hypertension and a region on chromosome 2. The 2B-adrenoceptor gene, a candidate gene within this region, harbors a functional insertion/deletion (I/D) polymorphism of three glutamate residues. The aim of this study was to investigate
if the DD genotype is associated with hypertension in Swedes. We performed an association study between the I/D
polymorphism of the 2B-adrenoceptor and hypertension in the Skaraborg population. The material consists of all known
patients with primary hypertension in Skara (n772 nondiabetic subjects; n171 normoalbuminuric type 2 diabetic
subjects) and 817 population control subjects. We first compared genotype frequencies between patients with
early-onset hypertension (aged 50 years or younger at onset) and subjects with normotension (blood pressure
120/80 mm Hg). Thereafter, the polymorphism was tested for association with hypertension at the population level.
When comparing patients with early-onset hypertension and normotensive subjects, the DD versus II genotype was
associated with early-onset hypertension when diabetic subjects were excluded from the analysis (OR2.0; 95%
CI1.2 to 3.5) or when they were not excluded (OR1.8; 95% CI1.0 to 3.1). At the population level, the DD versus
II genotype was weakly associated with nondiabetic hypertension (OR1.4; 95% CI1.0 to 1.8). Our data suggest that carriers of the DD versus II genotype of the 2B-adrenoceptor are at increased risk for hypertension. The genotypic effect is most evident when comparing groups corresponding to the upper and lower tails of the blood pressure distribution in the population; however, in nondiabetic hypertensive subjects it is weakly detectable even at the population level.
if the DD genotype is associated with hypertension in Swedes. We performed an association study between the I/D
polymorphism of the 2B-adrenoceptor and hypertension in the Skaraborg population. The material consists of all known
patients with primary hypertension in Skara (n772 nondiabetic subjects; n171 normoalbuminuric type 2 diabetic
subjects) and 817 population control subjects. We first compared genotype frequencies between patients with
early-onset hypertension (aged 50 years or younger at onset) and subjects with normotension (blood pressure
120/80 mm Hg). Thereafter, the polymorphism was tested for association with hypertension at the population level.
When comparing patients with early-onset hypertension and normotensive subjects, the DD versus II genotype was
associated with early-onset hypertension when diabetic subjects were excluded from the analysis (OR2.0; 95%
CI1.2 to 3.5) or when they were not excluded (OR1.8; 95% CI1.0 to 3.1). At the population level, the DD versus
II genotype was weakly associated with nondiabetic hypertension (OR1.4; 95% CI1.0 to 1.8). Our data suggest that carriers of the DD versus II genotype of the 2B-adrenoceptor are at increased risk for hypertension. The genotypic effect is most evident when comparing groups corresponding to the upper and lower tails of the blood pressure distribution in the population; however, in nondiabetic hypertensive subjects it is weakly detectable even at the population level.
Department/s
- Translational Muscle Research
- Community Medicine
- Department of Clinical Sciences, Malmö
Publishing year
2004
Language
English
Pages
592-597
Publication/Series
Hypertension
Volume
43
Issue
592
Links
Document type
Journal article
Publisher
Lippincott Williams & Wilkins
Topic
- Cardiac and Cardiovascular Systems
Keywords
- receptors
- adrenergic
- genetics
- hypertension
Status
Published
Research group
- Genomics, Diabetes and Endocrinology
- Community Medicine
ISBN/ISSN/Other
- ISSN: 1524-4563